Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Magdalena Tudrujek"'
Autor:
Dorota Zarębska-Michaluk, Michał Brzdęk, Olga Tronina, Justyna Janocha-Litwin, Marek Sitko, Anna Piekarska, Jakub Klapaczyński, Anna Parfieniuk-Kowerda, Barbara Sobala-Szczygieł, Magdalena Tudrujek-Zdunek, Łukasz Laurans, Robert Flisiak
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background Eliminating hepatitis C virus (HCV) infections is a goal set by the World Health Organization. This has become possible with the introduction of highly effective and safe direct-acting antivirals (DAA) but limitations remain due t
Externí odkaz:
https://doaj.org/article/2b3b1b2c568045c6bb363b56381eaabf
Autor:
Dorota Zarębska-Michaluk, Michał Brzdęk, Olga Tronina, Justyna Janocha-Litwin, Marek Sitko, Anna Piekarska, Jakub Klapaczyński, Anna Parfieniuk-Kowerda, Barbara Sobala-Szczygieł, Magdalena Tudrujek-Zdunek, Łukasz Laurans, Robert Flisiak
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/5b7e89f676f94cfe9566ac55a25f5969
Autor:
Yanqin Du, Tanvi Khera, Zhaoli Liu, Magdalena Tudrujek-Zdunek, Anna Dworzanska, Markus Cornberg, Cheng-Jian Xu, Krzysztof Tomasiewicz, Heiner Wedemeyer
Publikováno v:
Biomedicines, Vol 11, Iss 6, p 1529 (2023)
Hepatitis C virus (HCV) infection is closely associated with lipid metabolism defects along with a high prevalence of hepatic steatosis. After HCV clearance, steatosis persists in many patients. However, the reasons behind this phenomenon are not com
Externí odkaz:
https://doaj.org/article/0ac59103fbca4b2fbcb50a95f87075b0
Autor:
Dorota Zarębska-Michaluk, Anna Piekarska, Jerzy Jaroszewicz, Jakub Klapaczyński, Marek Sitko, Magdalena Tudrujek-Zdunek, Krzysztof Tomasiewicz, Teresa Belica-Wdowik, Paweł Pabjan, Beata Lorenc, Agnieszka Czauż-Andrzejuk, Olga Tronina, Rafał Krygier, Witold Dobracki, Iwona Buczyńska, Krzysztof A. Simon, Dorota Dybowska, Waldemar Halota, Małgorzata Pawłowska, Jolanta Citko, Łukasz Laurans, Włodzimierz Mazur, Ewa Janczewska, Łukasz Socha, Zbigniew Deroń, Hanna Berak, Robert Flisiak
Publikováno v:
Archives of Medical Science, Vol 18, Iss 6, Pp 1460-1466 (2019)
Introduction Non-cirrhotic treatment-naive hepatitis C patients infected with genotype 1 can be treated with ledipasvir/sofosbuvir (LDV/SOF) for 8 weeks, but in practice this regimen is frequently extended up to 12 weeks at least in part due to insuf
Externí odkaz:
https://doaj.org/article/98c74331a41c48fab58d3002fa6f0ffa
Autor:
Ewa Janczewska, Dorota Zarębska-Michaluk, Hanna Berak, Anna Piekarska, Andrzej Gietka, Dorota Dybowska, Włodzimierz Mazur, Teresa Belica-Wdowik, Witold Dobracki, Magdalena Tudrujek-Zdunek, Zbigniew Deroń, Iwona Buczyńska, Marek Sitko, Agnieszka Czauż-Andrzejuk, Beata Lorenc, Jolanta Białkowska-Warzecha, Jolanta Citko, Łukasz Laurans, Jerzy Jaroszewicz, Łukasz Socha, Olga Tronina, Brygida Adamek, Andrzej Horban, Waldemar Halota, Barbara Baka-Ćwierz, Krzysztof Tomasiewicz, Krzysztof Simon, Aleksander Garlicki, Marta Wawrzynowicz-Syczewska, Robert Flisiak
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background According to the EASL and AASLD guidelines, the recommended treatment for patients who failed to achieve a sustained virologic response (SVR) on prior interferon-based triple therapy with protease inhibitors (PI), is a combination
Externí odkaz:
https://doaj.org/article/f74922258b364284bf1043b0ac680f8f
Autor:
Anna Dworzańska, Magdalena Tudrujek-Zdunek, Jerzy Mosiewicz, Lech Panasiuk, Krzysztof Tomasiewicz
Publikováno v:
Annals of Agricultural and Environmental Medicine, Vol 27, Iss 2, Pp 317-318 (2020)
Introduction Diagnostic procedure in Coronavirus Disease 2019 (COVID-19) is based mainly on performing real-time-reverse transcription-polymerase chain-reaction (RT-PCR), which has been accepted as the gold standard method. In some cases, such as mut
Externí odkaz:
https://doaj.org/article/7c147466637b427e898ce71b458bb09e
Autor:
Dorota Zarębska-Michaluk, Iwona Buczyńska, Krzysztof Simon, Magdalena Tudrujek-Zdunek, Ewa Janczewska, Dorota Dybowska, Marek Sitko, Beata Dobracka, Jerzy Jaroszewicz, Paweł Pabjan, Jakub Klapaczyński, Łukasz Laurans, Włodzimierz Mazur, Łukasz Socha, Olga Tronina, Miłosz Parczewski, Robert Flisiak
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2019 (2019)
Background and Aim. The development of interferon- (IFN-) free regimens substantially improved efficacy of treatment for HCV, but despite excellent effectiveness the failures still occur. The aim of our study was to evaluate the efficacy of retreatme
Externí odkaz:
https://doaj.org/article/f0b4cc9cd55c42378960d4bcea26b40e
Autor:
Michał Brzdęk, Dorota Zarębska-Michaluk, Piotr Rzymski, Beata Lorenc, Adam Kazek, Magdalena Tudrujek-Zdunek, Justyna Janocha-Litwin, Włodzimierz Mazur, Dorota Dybowska, Hanna Berak, Anna Parfieniuk-Kowerda, Jakub Klapaczyński, Marek Sitko, Barbara Sobala-Szczygieł, Anna Piekarska, Robert Flisiak
Publikováno v:
World Journal of Gastroenterology. 29:2015-2033
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa5b9741916ac5b8ada618b7a0ed4ef1
https://doi.org/10.3748/wjg.v29.i13.2015
https://doi.org/10.3748/wjg.v29.i13.2015
Autor:
Flisiak, Monika Pazgan-Simon, Jerzy Jaroszewicz, Krzysztof Simon, Beata Lorenc, Marek Sitko, Dorota Zarębska-Michaluk, Dorota Dybowska, Magdalena Tudrujek-Zdunek, Hanna Berak, Włodzimierz Mazur, Jakub Klapaczyński, Ewa Janczewska, Anna Parfieniuk-Kowerda, Robert
Publikováno v:
Journal of Personalized Medicine; Volume 13; Issue 7; Pages: 1111
Introduction: In Poland, active HCV infection affects between 0.4 and 0.5% of the population, i.e., about 150,000 people, while the number of patients with epilepsy is estimated to be 350,000–400,000. Currently available antiviral therapies show li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::14031d85f812130e9d1e70f4f6d6c884
Autor:
Dorota Zarębska-Michaluk, Michał Brzdęk, Jerzy Jaroszewicz, Magdalena Tudrujek-Zdunek, Beata Lorenc, Jakub Klapaczyński, Włodzimierz Mazur, Adam Kazek, Marek Sitko, Hanna Berak, Justyna Janocha-Litwin, Dorota Dybowska, Łukasz Supronowicz, Rafał Krygier, Jolanta Citko, Anna Piekarska, Robert Flisiak
Publikováno v:
World journal of gastroenterology. 28(45)
The revolution in treatment of patients with chronic hepatitis C virus (HCV) infection dates back to the introduction of direct-acting antivirals (DAAs). The increase in efficacy was most pronounced in patients infected with genotype (GT) 1b, as this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8438cb6191b094e9b29a32880ee8bfae
https://pubmed.ncbi.nlm.nih.gov/36533109
https://pubmed.ncbi.nlm.nih.gov/36533109